ICDcodes.org
FY2027

E13.355 — Other specified diabetes mellitus with stable proliferative diabetic retinopathy

Not billable

Is E13.355 billable?

No — E13.355 is a non-billable header code. E13.355 groups more specific codes and cannot be submitted on a claim. A valid ICD-10-CM code must be reported at the highest level of specificity available in its branch. Select one of the 4 billable codes beneath E13.355.

E13.355 at a glance

CodeE13.355
DescriptionOther specified diabetes mellitus with stable proliferative diabetic retinopathy
BillableNo — header code
Code setICD-10-CM FY2027
Valid for encountersOctober 1, 2026 – September 30, 2027

How is E13.355 listed in the Alphabetic Index?

These are the routes through the Alphabetic Index that lead to E13.355. They show the wording a clinician may have documented, which often differs from the Tabular description.

  • Diabetes, diabetic › specified type NEC › with › retinopathy › proliferative › with › stable proliferative diabetic retinopathy (mellitus) (sugar)

Excludes1 — never code together — inherited from Chapter 4

The conditions below can never be reported together with E13.355 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Excludes1 — never code together — inherited from E13

The conditions below can never be reported together with E13.355 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • diabetes (mellitus) due to autoimmune process (E10.-)
  • diabetes (mellitus) due to immune mediated pancreatic islet beta-cell destruction (E10.-)
  • diabetes mellitus due to underlying condition (E08.-)
  • drug or chemical induced diabetes mellitus (E09.-)
  • gestational diabetes (O24.4-)
  • neonatal diabetes mellitus (P70.2)
  • type 1 diabetes mellitus (E10.-)

Use additional code — inherited from E13

Report an additional code alongside E13.355 to fully describe the condition. E13.355 is sequenced first.

  • code to identify control using:
  • injectable non-insulin antidiabetic drugs (Z79.85)
  • insulin (Z79.4)
  • oral antidiabetic drugs (Z79.84)
  • oral hypoglycemic drugs (Z79.84)

What codes fall under E13.355? (4)

How long has E13.355 existed?

E13.355 first appears in FY2018 (FY2017 is not available, so it may have appeared then).

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.

What other codes are in the E13.35 family? (5)